These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21790109)

  • 21. Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography.
    Fjeldstad C; Bemben M; Pardo G
    J Clin Neurosci; 2011 Nov; 18(11):1469-72. PubMed ID: 21917458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical coherence tomography: another useful tool in a neuro-ophthalmologist's armamentarium.
    Subei AM; Eggenberger ER
    Curr Opin Ophthalmol; 2009 Nov; 20(6):462-6. PubMed ID: 19696668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying axonal loss after optic neuritis with optical coherence tomography.
    Costello F; Coupland S; Hodge W; Lorello GR; Koroluk J; Pan YI; Freedman MS; Zackon DH; Kardon RH
    Ann Neurol; 2006 Jun; 59(6):963-9. PubMed ID: 16718705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in imaging to support the development of novel therapies for multiple sclerosis.
    Miller DH; Altmann DR; Chard DT
    Clin Pharmacol Ther; 2012 Apr; 91(4):621-34. PubMed ID: 22398971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Optical coherence tomography in multiple sclerosis].
    Vidal-Jordana Á; Sastre-Garriga J; Montalban X
    Rev Neurol; 2012 May; 54(9):556-63. PubMed ID: 22532220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axonal loss and myelin in early ON loss in postacute optic neuritis.
    Klistorner A; Arvind H; Nguyen T; Garrick R; Paine M; Graham S; O'Day J; Grigg J; Billson F; Yiannikas C
    Ann Neurol; 2008 Sep; 64(3):325-31. PubMed ID: 18825673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neither retinal nor brain atrophy can be shown in patients with isolated unilateral optic neuritis at the time of presentation.
    Kallenbach K; Sander B; Tsakiri A; Wanscher B; Fuglø D; Larsen M; Larsson H; Frederiksen JL
    Mult Scler; 2011 Jan; 17(1):89-95. PubMed ID: 20847000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.
    Burkholder BM; Osborne B; Loguidice MJ; Bisker E; Frohman TC; Conger A; Ratchford JN; Warner C; Markowitz CE; Jacobs DA; Galetta SL; Cutter GR; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
    Arch Neurol; 2009 Nov; 66(11):1366-72. PubMed ID: 19901168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Optic neuropathy in multiple sclerosis].
    Petrescu S; Pascu R; Panea C; Voinea L; Badarau A; Nanea M; Romanitan O; Ciuluvica R
    Oftalmologia; 2008; 52(4):3-14. PubMed ID: 19354157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.
    Henderson AP; Altmann DR; Trip AS; Kallis C; Jones SJ; Schlottmann PG; Garway-Heath DF; Plant GT; Miller DH
    Brain; 2010 Sep; 133(9):2592-602. PubMed ID: 20566483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography.
    Costello F; Hodge W; Pan YI; Eggenberger E; Coupland S; Kardon RH
    Mult Scler; 2008 Aug; 14(7):893-905. PubMed ID: 18573837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is optical coherence tomography really a new biomarker candidate in multiple sclerosis?--A structural and functional evaluation.
    Gundogan FC; Demirkaya S; Sobaci G
    Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5773-81. PubMed ID: 18055831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.
    Sepulcre J; Murie-Fernandez M; Salinas-Alaman A; García-Layana A; Bejarano B; Villoslada P
    Neurology; 2007 May; 68(18):1488-94. PubMed ID: 17470751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optic neuritis and the evaluation of visual impairment in multiple sclerosis.
    Bermel RA; Balcer LJ
    Continuum (Minneap Minn); 2013 Aug; 19(4 Multiple Sclerosis):1074-86. PubMed ID: 23917102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optic neuritis and risk of MS: differential diagnosis and management.
    Osborne BJ; Volpe NJ
    Cleve Clin J Med; 2009 Mar; 76(3):181-90. PubMed ID: 19258465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical coherence tomography measures axonal loss in multiple sclerosis independently of optic neuritis.
    Albrecht P; Fröhlich R; Hartung HP; Kieseier BC; Methner A
    J Neurol; 2007 Nov; 254(11):1595-6. PubMed ID: 17987252
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of optical coherence tomography in multiple sclerosis and other neurological disorders--need more awareness among Pakistani medical professionals.
    Farooq MU
    J Pak Med Assoc; 2007 Apr; 57(4):218-9. PubMed ID: 17489537
    [No Abstract]   [Full Text] [Related]  

  • 38. Optical coherence tomography in neuromyelitis optica.
    de Seze J; Blanc F; Jeanjean L; Zéphir H; Labauge P; Bouyon M; Ballonzoli L; Castelnovo G; Fleury M; Defoort S; Vermersch P; Speeg C
    Arch Neurol; 2008 Jul; 65(7):920-3. PubMed ID: 18625858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients.
    Garcia-Martin E; Pueyo V; Almarcegui C; Martin J; Ara JR; Sancho E; Pablo LE; Dolz I; Fernandez J
    Br J Ophthalmol; 2011 Nov; 95(11):1577-82. PubMed ID: 21785155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic validity of optic disc and retinal nerve fiber layer evaluations in detecting structural changes after optic neuritis.
    Bertuzzi F; Suzani M; Tagliabue E; Cavaletti G; Angeli R; Balgera R; Rulli E; Ferrarese C; Miglior S
    Ophthalmology; 2010 Jun; 117(6):1256-1264.e1. PubMed ID: 20381872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.